FGCL-3019-087

  1. Home
  2. Research
  3. Projects
  4. FGCL-3019-087
Starting date
December 1, 2020
Duration (months)
36
Departments
Department of Engineering for Innovation Medicine
Managers or local contacts
Malleo Giuseppe

Trial di fase III randomizzato multicentrico, in doppio cieco, di pamrevlumbab o placebo in combinazione con gemcitabina più nab-paclitaxel come trattamento neoadiuvante in pazienti con adenocarcinoma pancreatico localmente avanzato non resecabile.

Project participants

Claudio Bassi
Deborah Bonamini
Luca Casetti
Matteo De Pastena
Alessandro Esposito
Martina Fontana
Luca Landoni
Giuseppe Malleo
Associate Professor
Giovanni Marchegiani
Michele Milella
Full Professor
Salvatore Paiella
Associate Professor
Roberto Salvia
Full Professor
Erica Secchettin
Technical-administrative staff
Massimiliano Tuveri
Camilla Zecchetto

Collaboratori esterni

Stefano Milleri
Centro Ricerche Cliniche Srl Direttore CRC
Irene Rossi
Centro Ricerche Cliniche Srl Data manager
Research areas involved in the project
Cancer Diagnosis
Cancer Genetics
Cancer Therapy (excl. Chemotherapy and Radiation Therapy)
Surgery
Sections
Chirurgia Generale e Pancreatica

Activities

Research areas

Research groups

Sections

PhD Programmes

Research facilities

Share